Biora Therapeutics, Inc. Accounts Receivable
Biora Therapeutics, Inc. had Accounts Receivable of $0 as of 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-03-30
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $0.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-30 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $653.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $1.92M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $5.05M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $13.21M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $6.63M 10-K · filed 2022-03-28 | $12.68M 10-K · filed 2021-03-18 |
| 2020-09-30 | $13.43M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $14.38M 10-Q · filed 2020-08-14 | |
| 2019-12-31 | $22.19M 10-K · filed 2021-03-18 |